Get startedLog in
    Picture of Formosa Pharmaceuticals logo

    6838 — Formosa Pharmaceuticals Cashflow Statement

    0.000.00%
    tw flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Formosa Pharmaceuticals, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

    2019
    December 31st
    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:PROSPECTUSPROSPECTUSAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-198-220-398-402-300
    Depreciation
    Amortisation
    Non-Cash Items2.538.2939.43.128.8
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-19.90.038-9.8713.634.7
    Change in Accounts Receivable
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-180-176-331-346-196
    Capital Expenditures-0.238-4.66-15.10-2.25
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-78.2-0.01-71-189-674
    Acquisition of Business
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-78.5-4.67-86.1-189-676
    Financing Cash Flow Items———58.40
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-1.641586055591,000
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-262-35.416758.4117